Dr. Collins awarded CIHR Project Grant

Date Posted: 
Dr. Colin Collins

Dr. Colin Collins has been awarded a five-year CIHR Project Grant for "Uncovering early mediators of lineage plasticity and validation of a metabolic vulnerability in neuroendocrine prostate cancer" (co-investigators: Dr. YZ Wang and Dr. Martin Gleave). 

This project will study two potential therapeutic approaches aimed at  preventing the onset of neuroendocrine prostate cancer (NEPC), which currently has no effective therapies for treatment or prevention.  Adenocarcinoma of the prostate ultimately progresses to castrate-resistant prostate cancer, which can become lethal NEPC through the process of neuroendocrine transdifferentiation (NEtD). By testing the effect of blocking pathways supsected to cause NEtD in model systems, the aim is to discover novel therapeutic targets.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.


Father's Day Walk-Run Fundraiser - June 20, 2021

The 23rd annual Father's Day Walk-Run takes place on Sunday June 20, as a virtual event.  Please consider donating to or joining our team as we raise funds to enable Prostate Cancer Foundation - BC to continue their funding of prostate cancer research and their support patients and their loved ones


Work at the Vancouver Prostate Centre

Tuesday, June 15, 2021

Dr. Zoubeidi awarded Canada Research Chair 1 in Cancer Therapy Resistance

Dr. Amina Zoubeidi
Friday, May 21, 2021

Professor Madanlal T. Wasan Memorial Prize in Urologic Sciences

Dr. Kishor Wasan (L) and Professor Madanlal T. Wasan (R)